Important Safety Information for Lantus®
Do not take Lantus® if you are allergic to insulin or any of the
inactive ingredients in Lantus®.
You must test your blood sugar levels while using insulin, such as Lantus®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision.
Do NOT dilute or mix Lantus® with any other insulin or solution.
It will not work as intended and you may lose blood sugar control, which could be
serious. Lantus® must only be used if the solution is clear and colorless
with no particles visible. Do not share needles, insulin pens or syringes with others.
The most common side effect of insulin, including Lantus®, is low
blood sugar (hypoglycemia), which may be serious. Some people may experience
symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia
may be serious and life threatening. It may cause harm to your heart or brain. Other
possible side effects may include injection site reactions, including changes in
fat tissue at the injection site, and allergic reactions, including itching and
rash. In rare cases, some allergic reactions may be life threatening.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Lantus®, tell your
doctor about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
Lantus® SoloSTAR® is a disposable prefilled insulin
pen. Please talk to your healthcare provider about proper injection technique and
follow instructions in the Instruction Leaflet that accompanies the pen.
Indications and Usage for Lantus®
Prescription Lantus® is a long-acting insulin used to treat adults
with type 2 diabetes and adults and children (6 years and older) with type 1 diabetes
for the control of high blood sugar. It should be taken once a day at the same time
each day to lower blood glucose. Do not use Lantus® to treat diabetic
ketoacidosis.
Please click here for full prescribing information for Lantus®
Important Safety Information for Apidra®
Do not use Apidra® during a low blood sugar reaction (hypoglycemia)
or if you are allergic to any of the ingredients in Apidra®.
You must test your blood sugar levels while using insulin, such as Apidra®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision. Apidra® must only be used if the solution is
clear and colorless with no particles visible. Do not share needles, insulin
pens or syringes with others.
Apidra®, when given by injection under the skin, should not
be mixed with insulins other than NPH. Do not mix Apidra® with any
insulin when used in the pump or for intravenous administration.
The most common side effect of insulin, including Apidra®, is low
blood sugar (hypoglycemia), which may be serious. Some people may experience
symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia
may be serious and life threatening. It may cause harm to your heart or brain. Other
possible side effects may include low blood potassium, injection site reactions,
such as changes in fat tissue at the injection site, and allergic reactions, such
as itching and rash. Less common, but potentially more serious or life-threatening,
is generalized allergy to insulin, including anaphylactic reactions.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Apidra®, tell your
doctor about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
Apidra® SoloSTAR® is a disposable prefilled insulin
pen. Please talk to your healthcare provider about proper injection techniques and
follow instructions in the Instruction Leaflet that accompanies the pen.
Indications and Usage for Apidra®
Prescription Apidra® is a rapid-acting insulin for adults with type
2 diabetes or adults and children (4 years and older) with type 1 diabetes to improve
blood sugar control. Apidra® given by subcutaneous injection is usually
used with a longer-acting insulin. When used as a mealtime insulin, Apidra®
should be given within 15 minutes before or within 20 minutes after starting a meal.
Please click here for full prescribing information for Apidra®
Important Safety Information for Lantus® SoloSTAR®
and Apidra® SoloSTAR®
Lantus® SoloSTAR® pen is grey and Apidra®
SoloSTAR® pen is blue. Each contains a different type of insulin
(long-acting vs. rapid-acting). Before using Lantus® SoloSTAR®
or Apidra® SoloSTAR®, carefully examine the label
on the pen to make sure you have the correct insulin.
Click here for information on Sharps Medical Waste Disposal.
The health information contained herein is provided for general educational purposes
only. Your healthcare professional is the single best source of information regarding
your health. Please consult your healthcare professional if you have any questions
about your health or treatment.
